ReviewFrontiers in medicine2026

Targeting molecular residual disease and immune escape in colorectal cancer recurrence: biomarker-guided immunotherapy and cell therapies.

Yang Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.